Key takeaways for California
- • No GLP-1 is FDA-approved for pre/post-bariatric use specifically.
- • Pre-op: liver shrinkage and risk optimization; post-op: regain management.
- • Observational data show 8-15% additional weight loss post-op on GLP-1.
- • Medi-Cal coverage rules apply for Bariatric Pre- and Post-Op Support patients in California — see Medicaid section below.
- • 13 GLP-1 telehealth providers available nationwide.
Why GLP-1 medications for Bariatric Pre- and Post-Op Support
No GLP-1 is FDA-approved specifically for bariatric pre/post-op support. Off-label preoperative use can reduce liver volume and improve surgical access; off-label postoperative use addresses the roughly 25-30% of bariatric patients who experience clinically significant weight regain. Evidence grade: C (observational data growing; few RCTs). The ASMBS 2022 statement and emerging 2024-2025 consensus recognize this as an evolving practice. Pancreatitis and gastroparesis risks may merit extra caution in altered post-op anatomy.
California-specific context
California has telehealth access concentrated in Los Angeles, San Diego, San Jose metros, with additional reach to San Francisco and Fresno. Kaiser Permanente, UCSF, Stanford Health, UCLA Health, Cedars-Sinai is the largest in-state academic medical center for endocrine + obesity-medicine specialty consults. The state health authority publishes prescribing + coverage updates at www.cdph.ca.gov.
Californiatelehealth & pricing rules
- • California requires a live video consultation before a GLP-1 prescription.
- • California allows new-patient telehealth prescribing without a prior in-person visit.
- • Typical cash GLP-1 price in California: ~$285/mo (compounded options often lower, brand higher).